Dennis Lee, PhD
Bill & Melinda Gates Foundation
Senior Program Officer in Chemistry Manufacturing & Controls
Dennis Lee is a Senior Program Officer in Chemistry Manufacturing & Controls at the Bill & Melinda Gates Foundation, where he oversees efforts on long-acting and other advanced drug delivery technologies. He began his career in 1992 as a medicinal chemist with SmithKline Beecham, and in 1999 joined Sunesis Pharmaceuticals, a start-up that developed molecular fragment-based approaches for drug discovery. He returned to GSK in 2001 and led a chemistry department in cardiovascular and urogenital diseases. Over the next several years, his group progressed a number of compounds into clinical development. Subsequently, Dennis headed Chemistry and Preclinical Development in the new Ophthalmology unit (2008) and was Director of Drug Delivery, Platform Technology and Sciences (2014), a newly-formed drug delivery group whose mission was to seek and develop novel drug delivery technologies that align with GSK’s portfolio.
He relocated to Seattle to join the Gates Foundation in July 2018, and is presently responsible for novel drug delivery technologies, including supporting an extensive portfolio of long-acting products for global health.